IP Library › Granted Patent US 9,117,680
Granted Patent B2
US 9,117,680 · App. 14/136,810 · Granted Aug 25, 2015

Biomedical electrode

Inventor: Andrew E. Fisk (Philadelphia, PA)
Assignee: Pulse Technologies Inc.
H01L21/042A61B5/04A61N1/05B23K26/0078H01L31/0224
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,117,680
App. No.
14/136,810
Granted
Aug 25, 2015
Kind
B2
Abstract

A biocompatible, implantable electrode for electrically active medical devices. The implantable medical electrode has a surface geometry which optimizes the electrical performance of the electrode, while mitigating the undesirable effects associated with prior art porous surfaces. The electrode has an optimized surface topography for improved electrical performance. Such a electrode is suitable for devices which may be permanently implanted in the human body as stimulation electrodes, such as pacemakers, or as sensors of medical conditions. Such is achieved by the application of ultrafast high energy pulses to the surface of a solid, monolithic electrode material for the purpose of increasing the surface area and thereby decreasing its after-potential polarization.

Claims (20)

1. An electrode comprising a solid, monolithic substrate having an outer peripheral surface; the outer peripheral surface having a topography defined by a plurality of discrete macro protrusions distributed about and extending outwardly from the outer peripheral surface, the macro protrusions having a width in the range of from about 0.15 μm to about 50 μm; a plurality of discrete micro protrusions distributed on and extending outwardly from the macro protrusions, the micro protrusions having a width ranging from about 0.15 μm to about 5 μm; and a plurality of discrete nano protrusions distributed on and extending outwardly from the micro protrusions, the nano protrusions having a width ranging from about 0.01 μm to about 1 μm.

2. The electrode of claim 1 wherein the macro protrusions are substantially uniformly distributed across the outer peripheral surface of the solid, monolithic substrate.

3. The electrode of claim 1 wherein the micro protrusions are distributed across the macro protrusions in the form of periodic waves of the heights of the micro protrusions.

4. The electrode of claim 1 wherein the nano protrusions are distributed across the micro protrusions in the form of tubes and/or globules.

5. The electrode of claim 1 wherein the macro protrusions have a width in the range of from about 0.2 μm to about 30 μm; the micro protrusions have a width in the range of from about 0.2 μm to about 2 μm; and the nano protrusions have a width in the range of from about 0.02 μm to about 1 μm.

6. The electrode of claim 1 wherein the macro protrusions have a width in the range of from about 1 μm to about 20 μm; the micro protrusions have a width in the range of from about 0.4 μm to about 1.5 μm; and the nano protrusions have a width in the range of from about 0.075 μm to about 0.8 μm.

7. The electrode of claim 1 wherein the substrate comprises a biocompatible metal.

8. The electrode of claim 1 wherein the substrate comprises platinum, steel, an alloy of platinum and iridium, an alloy of nickel and cobalt, titanium, an alloy of titanium, tantalum or combinations thereof.

9. The electrode of claim 1 wherein the outer peripheral surface further comprises a plurality of voids distributed about the outer peripheral surface and extending a depth through the substrate; said voids having a depth through the substrate of from about 50 nm to about 500 nm; and said voids having a width of from about 50 nm to about 500 nm; said voids being spaced from adjacent voids a distance of from about 50 nm to about 250 nm.

10. The electrode of claim 1 which has a configuration suitable for implanting within tissues of a mammal.

11. The electrode of claim 1 having an outer peripheral surface area of from about 1 mm 2 to about 20 mm 2 .

12. The electrode of claim 1 further comprising at least one electrical connector electrically attached at an end thereof to the substrate.

13. The electrode of claim 12 further comprising an electrical pulse generator attached to another end of said electrical connector.

14. The electrode of claim 12 further comprising an electrical measurement device attached to another end of said electrical connector.

15. A method which comprises implanting the electrode of claim 1 within tissues of a mammal.

16. A method for producing an electrode comprising a solid, monolithic substrate having an outer peripheral surface; the outer peripheral surface having a topography defined by a plurality of discrete macro protrusions distributed about and extending outwardly from the outer peripheral surface, the macro protrusions having a width in the range of from about 0.15 μm to about 50 μm; a plurality of discrete micro protrusions distributed on and extending outwardly from the macro protrusions, the micro protrusions having a width ranging from about 0.15 μm to about 5 μm; and a plurality of discrete nano protrusions distributed on and extending outwardly from the micro protrusions, the nano protrusions having a width ranging from about 0.01 μm to about 1 μm; the method comprising exposing a solid, monolithic substrate to pulses of laser irradiation having a laser spot diameter ranging from about 1 μm to about 1000 μm, wherein the number of pulses of laser irradiation per spot, ranges from about 10 to about 1500 pulses, the pulse wavelength ranges from about 200 nm to about 1500 nm, the pulse width ranges from about 1 femtosecond to about 5 picoseconds; at a irradiance of from about 200 watts/cm 2 to about 5000 watts/cm 2 .

17. The method of claim 16 wherein the exposing is conducted by traversing the spot of laser radiation across the outer peripheral surface of the solid, monolithic substrate at a rate of from about 50 mm/min to about 1000 mm/min.

18. The method of claim 16 wherein the substrate comprises a biocompatible metal.

19. The method of claim 16 wherein the laser has a spot diameter ranging from about 2 μm to about 250 μm; the number of pulses of laser irradiation per spot ranges from about 20 to about 1000; the laser has a pulse wavelength which ranges from about 400 to about 1,000; and the laser pulse width ranges from about 1 femtoseconds to about 3 picoseconds.

20. The method of claim 16 wherein the laser has a spot diameter ranging from about 5 μm to about 200 μm; the number of pulses of laser irradiation per spot ranges from about 100 to about 500; the laser has a pulse wavelength which ranges from about 400 to about 800; the laser pulse width ranges from about 1 femtoseconds to about 3 picoseconds.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 13, 2018
From: PULSE TECHNOLOGIES, INC.
To: PULSE IP, LLC
Reel/Frame 046071/0698 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 20, 2013
From: FISK, ANDREW E.
To: PULSE TECHNOLOGIES, INC.
Reel/Frame 031831/0795 →
Continuity (1)
Related Publication 20150173635A1 · Jun 25, 2015